MOPEAD presented during the Alzheimer Europe annual conference in Berlin

 

Alzheimer Europe organised a Symposium supported by Eli Lilly on 4 October 2017 at its annual conference in Berlin.

 

The symposium titled “Engaging with Patient Organizations within the IMI Consortia to inform quality, relevance and value in Alzheimer’s research – insights from MOPEAD, EPAD and ROADMAP”, explored how these three public-private consortia sponsored by Horizon 2020 under the auspices of IMI and EFPIA, are tackling AD across its continuum.

Share on Facebook
Share on Twitter
Please reload

Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

©2018 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations